1-hexadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Term ID

CHEBI:86248

Synonyms

(2R)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy}-3-(hexadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate
1-Palmityl-2-docosahexaenoyl-sn-glycero-3-phosphocholine
PC(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Definition

A phosphatidylcholine O-38:6 in which the alkyl and acyl groups specified at positions 1 and 2 are hexadecyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.

References

HMDB:HMDB0013409
LIPID_MAPS_instance:LMGP01020064

Ontology

ChEBI ( EBI )

Relationships

is a type of: 2-acyl-1-alkyl-sn-glycero-3-phosphocholine phosphatidylcholine O-38:6

2-acyl-1-alkyl-sn-glycero-3-phosphocholine phosphatidylcholine O-38:6 Show first 5 Terms
has_functional_parent: all-cis-docosa-4,7,10,13,16,19-hexaenoic acid

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Show first 5 Terms

Phenotype

Phenotype resulting from 1-hexadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Phenotype where environments contain 1-hexadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Phenotype modified by environments containing 1-hexadecyl-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl]-sn-glycero-3-phosphocholine

Human Disease Model